|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.740 USD | -0.34% |
|
-8.96% | +12.05% |
| 05-13 | BioCryst Pharmaceuticals, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 01:40 PM | |
| 05-06 | BioCryst Pharmaceuticals, Inc., Q1 2026 Earnings Call, May 06, 2026 |
| Capitalization | 2.22B 1.91B 1.75B 1.65B 3.05B 215B 3.1B 20.73B 8.11B 101B 8.34B 8.16B 353B | P/E ratio 2026 * |
-3.74x | P/E ratio 2027 * | 24.1x |
|---|---|---|---|---|---|
| Enterprise value | 2.22B 1.91B 1.75B 1.65B 3.05B 215B 3.1B 20.73B 8.11B 101B 8.34B 8.16B 353B | EV / Sales 2026 * |
3.31x | EV / Sales 2027 * | 3.05x |
| Free-Float |
94.41% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioCryst Pharmaceuticals, Inc.
| 1 day | -0.34% | ||
| 1 week | -8.96% | ||
| Current month | -4.59% | ||
| 1 month | -4.90% | ||
| 3 months | +17.32% | ||
| 6 months | +24.32% | ||
| Current year | +12.05% |
| 1 week | 8.72 |  | 9.59 |
| 1 month | 7.78 | | 9.82 |
| Current year | 6.23 | | 10.32 |
| 1 year | 6 | | 11.31 |
| 3 years | 4.03 | | 11.31 |
| 5 years | 4.03 | | 19.99 |
| 10 years | 1.38 | | 19.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charles Gayer
CEO | Chief Executive Officer | 55 | 01/01/2026 |
Babar Ghias
DFI | Director of Finance/CFO | 47 | 07/07/2025 |
Sandeep Menon
CTO | Chief Tech/Sci/R&D Officer | - | 06/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Theresa Heggie
BRD | Director/Board Member | 65 | 03/12/2018 |
Alan Levin
BRD | Director/Board Member | 64 | 27/02/2020 |
| Chairman | 62 | 29/12/2025 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.34% | -8.96% | -15.39% | +3.55% | 2.22B | |
| -0.09% | -0.63% | +32.20% | +76.74% | 49.93B | |
| +1.29% | -5.34% | +64.54% | +53.42% | 45.92B | |
| +0.47% | -8.54% | +57.51% | +454.52% | 23.39B | |
| +2.93% | -2.03% | -11.17% | -15.15% | 22.85B | |
| -0.91% | +0.61% | +32.96% | -26.29% | 17.51B | |
| +0.46% | +2.57% | +26.11% | -40.45% | 16.45B | |
| +4.35% | -3.07% | +36.52% | +217.04% | 13.52B | |
| +3.80% | +4.32% | +34.68% | - | 13.01B | |
| +12.87% | -4.79% | -26.65% | +964.88% | 13.89B | |
| Average | +2.48% | -2.80% | +23.13% | +187.59% | 21.87B | |
| Weighted average by Cap. | +1.88% | -2.10% | +32.96% | +154.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 671M 577M 528M 499M 922M 64.81B 937M 6.26B 2.45B 30.6B 2.52B 2.46B 107B | 727M 625M 572M 541M 999M 70.24B 1.02B 6.79B 2.66B 33.16B 2.73B 2.67B 115B |
| Net income | -670M -576M -528M -498M -921M -64.73B -936M -6.25B -2.45B -30.56B -2.51B -2.46B -106B | 60.77M 52.26M 47.84M 45.2M 83.52M 5.87B 84.87M 567M 222M 2.77B 228M 223M 9.65B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/05/26 | 8.740 $ | -0.34% | 2,575,025 |
| 19/05/26 | 8.770 $ | -2.23% | 3,876,459 |
| 18/05/26 | 8.970 $ | -0.55% | 3,797,371 |
| 15/05/26 | 9.020 $ | -5.75% | 4,576,465 |
| 14/05/26 | 9.570 $ | -0.31% | 5,326,914 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BCRX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition